Ondansetron Accord (Ondansetron)

Ondansetron Accord is a selective 5‑HT3 receptor antagonist used to prevent and treat nausea and vomiting in several clinical settings.

• Chemotherapy‑induced nausea and vomiting: helps control acute and delayed episodes in cancer patients.
• Radiation‑induced nausea and vomiting: reduces the frequency and severity of symptoms during radiotherapy.
• Post‑operative nausea and vomiting: decreases the incidence of nausea after surgical procedures.
• Pregnancy‑related hyperemesis gravidarum: provides relief when other measures are insufficient.
• Anticipatory nausea: lessens nausea that occurs before chemotherapy in patients with a history of severe CINV.

• Ondansetron selectively blocks serotonin (5‑HT3) receptors located on vagal afferent nerves in the gastrointestinal tract and in the chemoreceptor trigger zone of the brain. By inhibiting these receptors, it prevents serotonin‑mediated activation of the vomiting centre, thereby reducing the initiation of nausea and vomiting signals.

Side effects are generally mild but can vary in frequency and severity.

Common Side Effects

• Headache: mild to moderate pain often reported.
• Constipation: reduced bowel movements.
• Diarrhoea: loose stools.
• Fatigue: feeling of tiredness.
• Dizziness: light‑headed sensation.
• Injection site pain (if administered parenterally).

Serious or Rare Side Effects

• Cardiac arrhythmia: QT‑interval prolongation may lead to irregular heart rhythm.
• Severe allergic reaction: rash, itching, swelling, or difficulty breathing.
• Serotonin syndrome: rare when combined with other serotonergic agents.
• Hepatic dysfunction: elevated liver enzymes.
• Vision changes: blurred vision or visual disturbances.
• Severe constipation or bowel obstruction.

Before using Ondansetron Accord, consider the following safety measures:

• Cardiac monitoring: patients with known QT prolongation or electrolyte imbalance should be monitored.
• Drug interactions: review concomitant medications that may affect cardiac rhythm.
• Pregnancy: use only if the potential benefit outweighs risk; discuss with a healthcare provider.
• Breastfeeding: assess risk versus benefit before use while nursing.
• Renal or hepatic impairment: dose adjustment may be required; consult prescriber.
• Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Ondansetron may interact with several medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid)

• Amiodarone: may increase risk of QT prolongation.
• Certain anti‑arrhythmic drugs (e.g., sotalol, quinidine): additive effect on cardiac repolarization.
• Antifungal agents (e.g., ketoconazole, itraconazole): can raise ondansetron plasma levels.

Moderate Interactions (Monitor Closely)

• Selective serotonin reuptake inhibitors (SSRIs) and serotonin‑norepinephrine reuptake inhibitors (SNRIs): may increase serotonin syndrome risk.
• Tramadol and other opioids: combined use may heighten serotonin‑related adverse effects.
• Carbamazepine: may reduce ondansetron concentrations.
• Metoclopramide: overlapping anti‑emetic mechanisms may require dose adjustment.